Nuva Ring Lawsuit
Nuva Ring Lawsuit Information
NuvaRing is a birth control device developed by Organon a multi-billion dollar European pharmaceutical company.
Nuva Ring works by releasing estrogen and progesterone into the bloodstream. It releases estrogen and progesterone into the bloodstream. However, these high levels of hormones are known cause blood clotting issues, such as blood clots and could cause severe health consequences.
The increased health risks related to Nuva Ring include but are not limited to;
* Heart Attacks
* Cerebral Hemorrhaging
* Cardiovascular Accidents
* Myocardial Infarction
* Pulmonary Embolisim
These side effects were known and documented for several years, yet the public was never warned and Nuva Ring was sold and marketed to U.S. consumers.
Birth control products utilizing the manipulation of hormone levels have been on the market for many years, and have undergone their share of controversy in the medical community. Many have proven to be relatively safe; some have remained controversial and at least one is now being sited in multiple lawsuits as the cause of serious medical problems and at least one fatality.
NuvaRing is an internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. The manufacturer is the Organon Pharmaceuticals, working in conjunction with Schering Plough to market the product. NuvaRing releases two synthetically produced hormones, progestin and an estrogen, into the woman’s body. The combination of these hormones is designed to both prevent ovulation and minimize sperm penetration – a double phalanx against unwanted pregnancy.
Use of the device over the past seven years has shown that side effects of NuvaRing can include vaginitis, headache, nausea, and possible upper respiratory tract infections that include sinusitis. More serious problems have also developed in the form of blood clots that can cause deep vein thrombosis and life threatening pulmonary embolism.
NuvaRing has been described as a third-generation birth control product using a form of synthetic progestin called desogestrel. Use of this particular synthesized version of the hormone has been associated with a higher risk of blood clots in women when compared with the use of earlier contraceptives that used the same scientific concept with different formulations of progestin.
Fifty or more NuvaRing lawsuits have been filed as the result of blood clotting problems resulting in deep vein thrombosis or pulmonary embolism, which is clotting in the primary artery feeding oxygen to the lungs. There is discussion of a class action lawsuit against Organon and affiliated companies over this birth control device and some women have already taken the step of filing legal action on their own.
In 2005, the FDA issued a warning about NuvaRing that detailed reports of abnormal bleeding and spotting from use of the device, as well as advising that “the increased risk of thromboembolic and thrombotic disease associated with use of the vaginal ring, it should not be used in women with valvular heart disease and thrombogenic complications.”
The operative notation in this warning with respect to blood clotting is the increased risk of thromboemolism, which is a condition wherein a blood clot breaks loose from its formation location and is carried through the bloodstream to another point where it creates blockage. The NuvaRing lawsuits are based on occurrences that have been observed by medical authorities and commented on by the FDA at least three years ago.
If you or a family member is exhibiting any of the symptoms associated with the use of the NuvaRing including blood clotting health problems, contact our law firm for a free review of your case and some suggestions about how to act on it.